AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24249680
Drug: Pharmacist-initiated multidisciplinary
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Pharmacist-initiated multidisciplinary strategy (education, pain medication management, physiotherapy-guided exercise, communication with primary care physician)
Trial: 23113511
Drug: Non-thermal, non-ablative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-thermal, non-ablative CO(2) laser therapy (NACLT)
Trial: 15712100
Drug: Levofloxacin (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin (750 mg iv q24h)
Trial: 15712100
Drug: Imipenem-cilastatin (500-1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipenem-cilastatin (500-1000 mg iv q6-8h)
Trial: 7598139
Drug: Step-One diet
RxNorm normalized name: PostDay One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Step-One diet plus continuous combined hormone-replacement therapy (conjugated estrogens 0.625 mg/d plus medroxyprogesterone 2.5 mg/d)
Trial: 2222986
Drug: 80 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg/day of baclofen
Trial: 26553894
Drug: Multifaceted intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multifaceted intervention including academic detailing, web-based treatment algorithms, and tailored patient information leaflets
Trial: 21906314
Drug: Chlorella-derived multicomponent
RxNorm normalized name: Chlorella emersonii extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorella-derived multicomponent supplement (30 tablets per day for 4 weeks)
Trial: 21906314
Drug: Placebo (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (30 tablets per day for 4 weeks)
Trial: 12649401
Drug: Chimeric anti-TNFalpha
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chimeric anti-TNFalpha antibodies (3 mg/kg, bimonthly i.v.)
Trial: 8055999
Drug: Oral isosorbide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral isosorbide mononitrate
Trial: 2648642
Drug: Ranitidine treatment,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine treatment, 150 mg twice daily for four weeks
Trial: 25138784
Drug: Gabapentin (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (600 mg)
Trial: 25987833
Drug: Generic clopidogrel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Generic clopidogrel bisulfate 75 mg film‐coated tablets
Trial: 25987833
Drug: Plavix® clopidogrel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plavix® clopidogrel bisulfate 75 mg film‐coated tablets
Trial: 17598007
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UFH) - 5,000 IU iv bolus followed by 450 IU/kg/24 h for 72 hours (n = 7)
Trial: 17598007
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (LMWH; dalteparin) - 200 IU/kg sc once daily for 72 hours (n = 8)
Trial: 17598007
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (LMWH; dalteparin) - 100 IU/kg sc once (n = 8)
Trial: 11531036
Drug: Reparil‐Gel N
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reparil‐Gel N (n = 32)
Trial: 11531036
Drug: Reparil‐Gel (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reparil‐Gel (n = 31)
Trial: 11531036
Drug: Placebo gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo gel (n = 31)
Trial: 1460184
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (75 mg Zn/day)
Trial: 1460184
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (75 mg Zn/day) in bulimics
Trial: 1460184
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (75 mg Zn/day) in anorexics
Trial: 2866965
Drug: bopindolol 1.35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bopindolol 1.35 mg/day
Trial: 2866965
Drug: metoprolol 144
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoprolol 144 mg/day
Trial: 2866965
Drug: bopindolol 1
RxNorm normalized name: bopindolol 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bopindolol 1 mg o.d. and 8 mg once weekly
Trial: 2866965
Drug: bopindolol long-term
RxNorm normalized name: bopindolol
DrugBank: Bopindolol (DB08807)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bopindolol long-term therapy
Trial: 2866965
Drug: bopindolol treatment
RxNorm normalized name: bopindolol
DrugBank: Bopindolol (DB08807)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bopindolol treatment withdrawal
Trial: 30755452
Drug: Imarikiren 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imarikiren 5 mg
Trial: 30755452
Drug: Imarikiren 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imarikiren 20 mg
Trial: 30755452
Drug: Imarikiren 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imarikiren 40 mg
Trial: 14694250
Drug: Continuous Positive
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous Positive Airways Pressure (CPAP) treatment
Trial: 14694250
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of CPAP treatment
Trial: 9836209
Drug: Midazolam 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.25 mg.kg‐1
Trial: 11391326
Drug: Fluticasone nasal
RxNorm normalized name: fluticasone nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone nasal spray
Trial: 2223156
Drug: Bestatin combination
RxNorm normalized name: Nystatin
DrugBank: Nystatin (DB00646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bestatin combination therapy (30 mg daily)
Trial: 526384
Drug: i.v. ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. ketamine 2 mg/kg body weight
Trial: 371650
Drug: ergometrine 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ergometrine 0.5 mg
Trial: 526384
Drug: intra-cervical 0.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: intra-cervical 0.5% lignocaine 20 ml
Trial: 30894455
Drug: Lacnotuzumab (0.01-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lacnotuzumab (0.01-20 mg/kg)
Trial: 30894455
Drug: Lacnotuzumab (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lacnotuzumab (5 or 10 mg/kg)
Trial: 19961377
Drug: Microthreads placed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Microthreads placed at the implant top (group A)
Trial: 19961377
Drug: Microthreads placed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Microthreads placed 0.5 mm below the implant top (group B)
Trial: 17085674
Drug: Aspirin intervention
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin intervention
Trial: 19333080
Drug: Japanese encephalitis
RxNorm normalized name: Japanese Encephalitis IM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Japanese encephalitis vaccine
Trial: 3540212
Drug: Acyclovir, 45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir, 45 mg/kg/day as a continuous IV infusion for 28 days
Trial: 15666120
Drug: Low-dose etidronate
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose etidronate (200 mg daily for 2 weeks followed by 12 weeks of calcium supplementation of 500 mg/day)
Trial: 15666120
Drug: High-dose etidronate
RxNorm normalized name: etidronate
DrugBank: Etidronic acid (DB01077)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-dose etidronate (400 mg daily for 2 weeks followed by 12 weeks of calcium supplementation of 500 mg/day)
Trial: 15666120
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment with osteoactive drugs)
Trial: 12897639
Drug: Selegiline 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selegiline 15 mg/day for 3 weeks
Trial: 10526278
Drug: Chemotherapy (idarubicin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (idarubicin, methylprednisolone, high dose ara-C)
Trial: 8682147
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml kg‐1 of Ringer acetate solution without glucose
Trial: 8682147
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml kg‐1 of Ringer acetate solution with 0.5% glucose
Trial: 6295132
Drug: Wheat bran
RxNorm normalized name: Wheat bran
DrugBank: Wheat bran (DB10685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat bran feeding (0.5 g/kg body weight)
Trial: 6295132
Drug: Exercise training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise training (4 mile walk‐jog run program 3 times weekly)
Trial: 30900607
Drug: 200 mL
RxNorm normalized name: Bag Top-Fill, 1200 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mL
Trial: 30900607
Drug: 250 mL
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mL
Trial: 30900607
Drug: 300 mL
RxNorm normalized name: HYQVIA 30 GM / 300 ML Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mL
Trial: 23008509
Drug: Sustained anticoagulation
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained anticoagulation (warfarin)
Trial: 21029995
Drug: HighCPAP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HighCPAP treatment
Trial: 21029995
Drug: LowCPAP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LowCPAP treatment
Trial: 12063520
Drug: HFA-BDP (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HFA-BDP (200 microg twice daily)
Trial: 12063520
Drug: DPI-BDP (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DPI-BDP (1000 microg twice daily for 4 weeks)
Trial: 9877478
Drug: Liquid oxygen
RxNorm normalized name: OXYGEN 99 L in 100 L RESPIRATORY (INHALATION) GAS [Liquid Oxygen]
DrugBank: Oxygen (DB09140)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liquid oxygen (L)
Trial: 7634630
Drug: Ketorolac 60
RxNorm normalized name: ketorolac 60 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 60 mg intraoperatively and 30 mg every 8 hours for 5 doses postoperatively
Trial: 2224948
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus Nicardipine
Trial: 346049
Drug: Prednisone (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (80 mg orally for 2 days)
Trial: 346049
Drug: Prednisone with
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone with aspirin
Trial: 346049
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with aspirin
Trial: 19505878
Drug: Sargramostim 6
RxNorm normalized name: Sargramostim
DrugBank: Sargramostim (DB00020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sargramostim 6 microg/kg subcutaneously once daily
Trial: 21518561
Drug: Prophylactic antibiotic
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotic use
Trial: 1090684
Drug: 1% tolnaftate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% tolnaftate cream
Trial: 1303075
Drug: 10% w/w
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% w/w tea tree oil cream
Trial: 22552566
Drug: Telmisartan 80
RxNorm normalized name: telmisartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan 80 mg a day
Trial: 22552566
Drug: Ramipril 10
RxNorm normalized name: ramipril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril 10 mg a day
Trial: 18378520
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (ramipril + telmisartan)
Trial: 15758247
Drug: Rosiglitazone 4
RxNorm normalized name: rosiglitazone 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone 4 mg/d for 4 weeks
Trial: 11422263
Drug: Imidazolidinyl urea
RxNorm normalized name: Imidazolidinyl urea
DrugBank: Imidurea (DB14075)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imidazolidinyl urea (IMID) patch test at concentrations from 0 to 600 microg/cm(2)
Trial: 8487648
Drug: Acipimox (500-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acipimox (500-mg capsules)
Trial: 3552921
Drug: Propranolol (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (160 mg long-acting per day)
Trial: 17551726
Drug: High-energy extracorporeal
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-energy extracorporeal shock wave treatment (ESWT; 1,500 shocks at 18 kV, 0.22 mJ/mm(2) without local anaesthesia)
Trial: 16899517
Drug: Controlled individualized
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Controlled individualized calcineurin inhibitor exposure
Trial: 14986815
Drug: Low daily
RxNorm normalized name: SODIUM FLUORIDE 2.43 mg in 1 g DENTAL PASTE, DENTIFRICE [Auraglow Daily]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low daily doses of IFN‐alpha2b (1.5 MU) 'consolidation therapy' for 1 year
Trial: 25549483
Drug: Infusion therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion therapy with sodium chloride 0.9%
Trial: 25549483
Drug: No infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No infusion therapy
Trial: 18991514
Drug: Nigella sativa
RxNorm normalized name: NIGELLA SATIVA SEED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nigella sativa seed aqueous extract (0.375 mL/kg of 50 g% boiled extract)
Trial: 19969339
Drug: Budesonide/formoterol combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol combination therapy
Trial: 10027654
Drug: GHB 25
RxNorm normalized name: GHB
DrugBank: gamma-Hydroxybutyric acid (DB01440)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GHB 25 mg x kg(‐1)
Trial: 19733712
Drug: Spot drug-eluting
RxNorm normalized name: Cold Spot
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spot drug-eluting stenting (spot DES)
Trial: 11502527
Drug: Clinafloxacin 200
RxNorm normalized name: Finafloxacin
DrugBank: Finafloxacin (DB09047)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clinafloxacin 200 mg
Trial: 8777381
Drug: Methimazole (MMI)
RxNorm normalized name: Methimazole
DrugBank: Methimazole (DB00763)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methimazole (MMI) low-dose regimen starting with 45 mg/day, lowering dose thereafter
Trial: 8777381
Drug: Methimazole (MMI)
RxNorm normalized name: Methimazole
DrugBank: Methimazole (DB00763)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methimazole (MMI) 60 mg/day + levothyroxine
Trial: 8777381
Drug: Methimazole (MMI)
RxNorm normalized name: Methimazole
DrugBank: Methimazole (DB00763)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methimazole (MMI) 30 mg/day + levothyroxine
Trial: 1853688
Drug: Intravenous ketoprofen
RxNorm normalized name: Ketoprofen
DrugBank: Ketoprofen (DB01009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ketoprofen 1.5 mg.ml‐1
Trial: 1853688
Drug: Pethidine 1
RxNorm normalized name: Pethidine
DrugBank: Meperidine (DB00454)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pethidine 1 mg.kg‐1
Trial: 27123743
Drug: HBV vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HBV vaccine (Engerix-B™, GSK Vaccines, Belgium) administered in 3 doses according to a 0, 1, 6 months schedule.
Trial: 22682949
Drug: Sitagliptin +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin + Metformin
Trial: 15742005
Drug: Rofecoxib 25
RxNorm normalized name: rofecoxib 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib 25 mg daily for up to 4 years
Trial: 10064664
Drug: Fast feed
RxNorm normalized name: Fast Freeze
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fast feed advancement (35 cc/kg/d increments, 5-day schedule to full feeds)
Trial: 25296066
Drug: internet-delivered cognitive
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: internet-delivered cognitive behaviour therapy (iCBT)
Trial: 22901359
Drug: OROS methylphenidate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OROS methylphenidate 54-72 mg/d
Trial: 17084625
Drug: 2.0% DHEA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0% DHEA cream applied twice daily
Trial: 16433809
Drug: Placebo applied
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo applied twice daily
Trial: 11801579
Drug: AmBisome (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AmBisome (3 or 5 mg/kg/day)
Trial: 2228983
Drug: Conventional electroconvulsive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional electroconvulsive therapy (ECT)
Trial: 528125
Drug: Phentermine resin
RxNorm normalized name: phentermine resin
DrugBank: Phentermine (DB00191)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phentermine resin 30 mg for eight weeks followed by placebo for eight weeks (Group 1)
Trial: 23536720
Drug: Onartuzumab (MetMAb,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Onartuzumab (MetMAb, OA5D5v2) administered i.v. once every three weeks in combination with erlotinib
Trial: 23536720
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered in combination with erlotinib
Trial: 12903918
Drug: Systemic cephazolin
RxNorm normalized name: Cephazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic cephazolin administration (3 g x day(-1) for 5 days) without oral cleansing
Trial: 14985668
Drug: Oral phenytoin
RxNorm normalized name: Phenytoin
DrugBank: Phenytoin (DB00252)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral phenytoin
Trial: 7125336
Drug: Low-dose naloxone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose naloxone (0.8 mg)
Trial: 7125336
Drug: High-dose naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose naloxone (10 mg)
Trial: 10612553
Drug: Magnesium sulphate
RxNorm normalized name: Magnesium sulphate
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium sulphate (MgSO4) infusion
Trial: 21640839
Drug: Citalopram (SSRI;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (SSRI; selective serotonergic reuptake inhibitor)
Trial: 15569338
Drug: Argatroban regimen
RxNorm normalized name: Argatroban
DrugBank: Argatroban (DB00278)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Argatroban regimen C: steady-state, 2-microg/kg/min infusion initiated 4 hours before dialysis
Trial: 11426017
Drug: High-dose d-penicillamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose d-penicillamine
Trial: 9298518
Drug: Amisulpride (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisulpride (800 mg/day)
Trial: 7961554
Drug: Clozapine treatment
RxNorm normalized name: Clozapine
DrugBank: Clozapine (DB00363)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clozapine treatment (continued treatment)
Trial: 7961554
Drug: Clozapine treatment
RxNorm normalized name: Clozapine
DrugBank: Clozapine (DB00363)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clozapine treatment with plasma concentrations above 350 ng/mL
Trial: 3498747
Drug: NSAIDs (specific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSAIDs (specific drugs include indomethacin and naproxen)
Trial: 3498747
Drug: NSAIDs (specifically
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSAIDs (specifically indomethacin, 150 mg/day)
Trial: 2148504
Drug: Methyldopa 250
RxNorm normalized name: methyldopa 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methyldopa 250 mg twice daily
Trial: 27307573
Drug: Chimpanzee adenovirus
RxNorm normalized name: COVID-19 VACCINE ADENOVIRUS-26
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chimpanzee adenovirus 63 and modified vaccinia virus Ankara-vectored vaccine expressing a multiepitope string fused to TRAP and 3 doses of RTS,S/AS01B (group 1; n=20)
Trial: 27307573
Drug: 3 doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3 doses of RTS,S/AS01B alone (group 2; n=17)
Trial: 17710003
Drug: Single injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single injection of bupivacaine and methylprednisolone at intervals of 4 to 5 days
Trial: 11496850
Drug: Quadruple therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadruple therapy (nelfinavir plus efavirenz and two nucleoside analogues)
Trial: 11496850
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy with efavirenz
Trial: 25888851
Drug: SrRan 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SrRan 2 g/day
Trial: 24660579
Drug: Seretide (salmeterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seretide (salmeterol 50 µg/fluticasone 250 µg, twice a day)
Trial: 10952955
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg folic acid daily for 12 weeks
Trial: 9663892
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg folic acid and 4 g betaine daily for 12 weeks
Trial: 9481724
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg folic acid daily for 40 weeks